• Return to Headlines

Abbott Labs: The Winning Streak Continues (ABT)

By Nick Russo

Abbott Labs (NYSE:ABT) traded at a new 52-week high today of $65.50. Approximately 2.6 million shares have changed hands today, as compared to an average 30-day volume of 4.8 million shares.

Potential upside of 5.3% exists for Abbott Labs, based on a current level of $64.73 and analysts' average consensus price target of $68.13. The stock should find initial support at its 50-day moving average (MA) of $61.85 and further support at its 200-day MA of $58.92.

Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company's products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.

In the past 52 weeks, shares of Abbott Labs have traded between a low of $48.05 and a high of $65.50 and are now at $64.73, which is 35% above that low price. Over the last five market days, the 200-day moving average (MA) has gone up 0.2% while the 50-day MA has advanced 0.4%.

SmarTrend is tracking the current trend status for Abbott Labs and will alert subscribers who have ABT in their portfolio or watchlist when shares have changed trend direction.

Keywords: 52 week high/lows abbott labs

Ticker(s): ABT